BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3901210)

  • 1. Clinical experience with imipenem/cilastatin: analysis of a multicenter study.
    Shah PM
    Rev Infect Dis; 1985; 7 Suppl 3():S471-5. PubMed ID: 3901210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open trial of imipenem/cilastatin therapy for serious bacterial infections.
    Brooks RG; McCabe RE; Vosti KL; Remington JS
    Rev Infect Dis; 1985; 7 Suppl 3():S496-505. PubMed ID: 3901213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.
    Wang C; Calandra GB; Aziz MA; Brown KR
    Rev Infect Dis; 1985; 7 Suppl 3():S528-36. PubMed ID: 3901217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients.
    Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; Antúnez de Mayolo E
    Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem/cilastatin therapy for serious bacterial infections.
    Nielsen DM; Katz JR; AhLoy RD; Hansen RS; Meyer RD
    Rev Infect Dis; 1985; 7 Suppl 3():S506-12. PubMed ID: 3901214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infections.
    Trumbore D; Pontzer R; Levison ME; Kaye D; Cynamon M; Liu C; Hinthorn DR; Tan JS; File TM
    Rev Infect Dis; 1985; 7 Suppl 3():S476-81. PubMed ID: 3931198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of imipenem/cilastatin on the colonic microflora.
    Nord CE; Kager L; Philipson A; Stiernstedt G
    Rev Infect Dis; 1985; 7 Suppl 3():S432-4. PubMed ID: 3863218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections.
    Diaz-Mitoma F; Harding GK; Louie TJ; Thomson M; James M; Ronald AR
    Rev Infect Dis; 1985; 7 Suppl 3():S452-7. PubMed ID: 3901207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience.
    Acar JF
    Rev Infect Dis; 1985; 7 Suppl 3():S513-7. PubMed ID: 3931199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin in the treatment of serious bacterial infections.
    Chiodini PL; Geddes AM; Smith EG; Conlon CP; Farrell ID
    Rev Infect Dis; 1985; 7 Suppl 3():S490-5. PubMed ID: 3901212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
    Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
    Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early clinical experience with imipenem-cilistatin.
    Ellis-Pegler RB; Downey D; Bremner DA
    N Z Med J; 1985 Mar; 98(775):188-91. PubMed ID: 3856762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem/cilastatin in the treatment of obstetric and gynecologic infections: a review of worldwide experience.
    Sweet RL
    Rev Infect Dis; 1985; 7 Suppl 3():S522-7. PubMed ID: 3901216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience.
    Kager L; Nord CE
    Rev Infect Dis; 1985; 7 Suppl 3():S518-21. PubMed ID: 3901215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem/cilastatin: general experience in a community hospital.
    Iannini PB; Kunkel MJ; Hilton E; Iannini GM
    Am J Med; 1985 Jun; 78(6A):122-6. PubMed ID: 3859211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections].
    Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
    Calandra G; Lydick E; Carrigan J; Weiss L; Guess H
    Am J Med; 1988 May; 84(5):911-8. PubMed ID: 3284342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.